» Articles » PMID: 34001980

Complement C5 is Not Critical for the Formation of Sub-RPE Deposits in Efemp1 Mutant Mice

Overview
Journal Sci Rep
Specialty Science
Date 2021 May 18
PMID 34001980
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The complement system plays a role in the formation of sub-retinal pigment epithelial (RPE) deposits in early stages of age-related macular degeneration (AMD). But the specific mechanisms that connect complement activation and deposit formation in AMD patients are unknown, which limits the development of efficient therapies to reduce or stop disease progression. We have previously demonstrated that C3 blockage prevents the formation of sub-RPE deposits in a mouse model of EFEMP1-associated macular degeneration. In this study, we have used double mutant Efemp1:C5 mice to investigate the role of C5 in the formation of sub-RPE deposits in vivo and in vitro. The data revealed that the genetic ablation of C5 does not eliminate the formation of sub-RPE deposits. Contrarily, the absence of C5 in RPE cultures promotes complement dysregulation that results in increased activation of C3, which likely contributes to deposit formation even in the absence of EFEMP1-R345W mutant protein. The results also suggest that genetic ablation of C5 alters the extracellular matrix turnover through an effect on matrix metalloproteinases in RPE cell cultures. These results confirm that C3 rather than C5 could be an effective therapeutic target to treat early AMD.

Citing Articles

The Complement System as a Therapeutic Target in Retinal Disease.

Ong J, Zarnegar A, Selvam A, Driban M, Chhablani J Medicina (Kaunas). 2024; 60(6).

PMID: 38929562 PMC: 11205777. DOI: 10.3390/medicina60060945.


Exploring ocular fibulin-3 (EFEMP1): Anatomical, age-related, and species perspectives.

Daniel S, Hulleman J Biochim Biophys Acta Mol Basis Dis. 2024; 1870(6):167239.

PMID: 38750770 PMC: 11238277. DOI: 10.1016/j.bbadis.2024.167239.


Bruch's Membrane: A Key Consideration with Complement-Based Therapies for Age-Related Macular Degeneration.

Hammadi S, Tzoumas N, Ferrara M, Meschede I, Lo K, Harris C J Clin Med. 2023; 12(8).

PMID: 37109207 PMC: 10145879. DOI: 10.3390/jcm12082870.


The extracellular microenvironment in immune dysregulation and inflammation in retinal disorders.

Biasella F, Plossl K, Baird P, Weber B Front Immunol. 2023; 14:1147037.

PMID: 36936905 PMC: 10014728. DOI: 10.3389/fimmu.2023.1147037.


Distinct Phenotypic Consequences of Pathogenic Mutants Associated with Late-Onset Retinal Degeneration.

Xu L, Ruddick W, Bolch S, Klingeborn M, Dyka F, Kulkarni M Am J Pathol. 2022; 193(11):1706-1720.

PMID: 36328299 PMC: 10726427. DOI: 10.1016/j.ajpath.2022.10.004.


References
1.
Hageman G, Anderson D, Johnson L, Hancox L, Taiber A, Hardisty L . A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A. 2005; 102(20):7227-32. PMC: 1088171. DOI: 10.1073/pnas.0501536102. View

2.
Smith-Jackson K, Yang Y, Denton H, Pappworth I, Cooke K, Barlow P . Hyperfunctional complement C3 promotes C5-dependent atypical hemolytic uremic syndrome in mice. J Clin Invest. 2019; 129(3):1061-1075. PMC: 6391106. DOI: 10.1172/JCI99296. View

3.
Anderson D, Radeke M, Gallo N, Chapin E, Johnson P, Curletti C . The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res. 2009; 29(2):95-112. PMC: 3641842. DOI: 10.1016/j.preteyeres.2009.11.003. View

4.
Bexborn F, Andersson P, Chen H, Nilsson B, Ekdahl K . The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb). Mol Immunol. 2007; 45(8):2370-9. PMC: 2701500. DOI: 10.1016/j.molimm.2007.11.003. View

5.
Mattapallil M, Wawrousek E, Chan C, Zhao H, Roychoudhury J, Ferguson T . The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes. Invest Ophthalmol Vis Sci. 2012; 53(6):2921-7. PMC: 3376073. DOI: 10.1167/iovs.12-9662. View